Prognostic value of posttreatment neutrophil–lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy

Auris Nasus Larynx

Volumn 44, Issue 2, 2017, Pages 199-204

  Kim, Do Young ^a   Kim, In Su ^a   Park, Sang Gyu ^a   Kim, Hyojeong ^a   Choi, Young Jin ^a   Seol, Young Mi ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Chemoradiotherapy; Head and neck squamous cell carcinomas; Neutrophil lymphocyte ratio; Prognosis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; DISEASE ASSOCIATION; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; BLOOD; CARCINOMA, SQUAMOUS CELL; CYTOLOGY; HEAD AND NECK NEOPLASMS; LYMPHOCYTE; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHIL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; C-REACTIVE PROTEIN; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84971612734     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2016.05.013     Document Type: Article

References (15)

1. [1] Forastiere, A., Koch, W., Trotti, A., Sidransky, D., Head and neck cancer. N Engl J Med 345 (2001), 1890–1900.
2. [2] Pignon, J.P., Bourhis, J., Domenge, C., Designé, L., Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000), 949–955.
3. [3] Bonomi, M., Patsias, A., Posner, M., Sikora, A., The role of inflammation in head and neck cancer. Adv Exp Med Biol 816 (2014), 107–127.
4. [4] Russell, S., Angell, T., Lechner, M., Liebertz, D., Correa, A., Sinha, U., et al. Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol, 5, 2013, 24.
5. [5] Rassouli, A., Saliba, J., Castano, R., Hier, M., Zeitouni, A.G., Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck 37 (2015), 103–110.
6. [6] Selzer, E., Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer: comparative analysis of inflammation-based prognostic scoring systems. Strahlenther Onkol 191 (2015), 486–494.
7. [7] Haddad, C.R., Guo, L., Clarke, S., Guminski, A., Back, M., Eade, T., Neutrophil-to-lymphocyte ratio in head and neck cancer. J Med Imaging Radiat Oncol 59 (2015), 514–519.
8. [8] Hekim, N., Cetin, Z., Nikitaki, Z., Cort, A., Saygili, E.I., Radiation triggering immune response and inflammation. Cancer Lett 368 (2015), 156–163.
9. [9] Mohammed, F.F., Poon, I., Zhang, L., Elliott, L., Hodson, I.D., Sagar, S.M., et al. Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer. Head Neck 34 (2012), 985–993.
10. [10] He, J.R., Shen, G.P., Ren, Z.F., Qin, H., Cui, C., Zhang, Y., et al. Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck 34 (2012), 1769–1776.
11. [11] Tsai, Y.D., Wang, C.P., Chen, C.Y., Lin, L.W., Hwang, T.Z., Lu, L.F., et al. Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck 36 (2014), 947–953.
12. [12] Millrud, C.R., Månsson Kvarnhammar, A., Uddman, R., Björnsson, S., Riesbeck, K., Cardell, L.O., The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS ONE, 7, 2012, e51120.
13. [13] Templeton, A.J., McNamara, M.G., Šeruga, B., Vera-Badillo, F.E., Aneja, P., Ocaña, A., et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst, 106, 2014, 124.
14. [14] Hag, A., Clark, R.A., Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol 139 (1987), 2406–2413.
15. [15] Fakhry, C., Westra, W.H., Li, S., Cmelak, A., Ridge, J.A., Pinto, H., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 (2008), 261–269.